Sökning: onr:"swepub:oai:DiVA.org:liu-174426" >
Adverse muscle comp...
Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD
-
- Linge, Jennifer (författare)
- Linköpings universitet,Avdelningen för samhälle och hälsa,Medicinska fakulteten,AMRA Medical AB, Linköping, Sweden
-
- Ekstedt, Mattias, 1976- (författare)
- Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Mag- tarmmedicinska kliniken
-
- Dahlqvist Leinhard, Olof, 1978- (författare)
- Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Centrum för medicinsk bildvetenskap och visualisering, CMIV,AMRA Medical AB, Linköping, Sweden
-
(creator_code:org_t)
- Elsevier, 2021
- 2021
- Engelska.
-
Ingår i: JHEP Reports. - : Elsevier. - 2589-5559. ; 3:1
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://liu.diva-por... (primary) (Raw object)
-
http://www.jhep-repo...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background & Aims: Sarcopenia and frailty are recognised as important factors in later stages of liver disease. However, theirrole in non-alcoholic fatty liver disease (NAFLD) is not yet fully understood. In this study we investigate the associations ofMRI-measured adverse muscle composition (AMC: low muscle volume and high muscle fat) with poor function, sarcopenia,and metabolic comorbidity within NAFLD in the large UK Biobank imaging study.Methods: A total of 9,545 participants were included. Liver fat, fat-tissue free muscle volume, and muscle fat infiltration werequantified using a rapid MRI protocol and automated image analysis (AMRA® Researcher). For each participant, a personalisedmuscle volume z-score (sex- and body size-specific) was calculated and combined with muscle fat infiltration for AMC detection. The following outcomes were investigated: functional performance (hand grip strength, walking pace, stairclimbing, falls) and metabolic comorbidities (coronary heart disease, type 2 diabetes). Sarcopenia was detected by combiningMRI thresholds for low muscle quantity and low hand grip strength according to the European working group definition.Results: The prevalence of sarcopenia in NAFLD (1.6%) was significantly lower (p <0.05) compared with controls without fattyliver (3.4%), whereas the prevalence of poor function and metabolic comorbidity was similar or higher. Of the 1,204 participants with NAFLD, 169 (14%) had AMC and showed 1.7–2.4× higher prevalence of poor function (all p <0.05) as well as 2.1×and 3.3× higher prevalence of type 2 diabetes and coronary heart disease (p <0.001), respectively, compared with thosewithout AMC.Conclusions: AMC is a prevalent and highly vulnerable NAFLD phenotype displaying poor function and high prevalence ofmetabolic comorbidity. Sarcopenia guidelines can be strengthened by including cut-offs for muscle fat, enabling AMCdetection.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Nyckelord
- AMC
- adverse muscle composition; CHD
- coronary heart disease; Cardiovascular disease; DXA
- dual-energy x-ray absorptiometry; Diabetes mellitus; FFMV
- fat-tissue free muscle volume; FIB-4
- fibrosis-4; Fatty liver; HbA1c
- glycated haemoglobin; MFI
- muscle fat infiltration; Magnetic resonance imaging; Myosteatosis; NAFLD
- non-alcoholic fatty liver disease; NASH
- non-alcoholic steatohepatitis; Non-alcoholic steatohepatitis; PDFF
- proton density fat fraction; Sarcopenia; Skeletal muscle; T2D
- type 2 diabetes; VCG
- virtual control group
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas